Análisis de la acción agilon health, inc. (AGL)AGLagilon health, inc.

agilon health, inc. is a healthcare company. The Company operates a Medicare-centric, capitated line of business. Through its combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, it offers healthcare for seniors across communities throughout the United States. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing monthly payments to manage the total healthcare needs of its physician partners attributed patients (or global capitation arrangements). It focuses on community-based physician groups and is built around three key elements: agilon’s platform, agilon’s long-term physician partnership approach, and agilon’s network. The agilon platform supports the transition to a Total Care Model with technology, people, process and capital. It operates in the Healthcare sector (SERVICES-MISC HEALTH & ALLIED SERVICES, NEC industry).

Agilon Health Inc. is a good buy right now due to its recent strong earnings performance, with Q2 2026 revenue of $1.49 billion exceeding expectations and adjusted EPS of $2.15 far surpassing the estimate of $0.27. Additionally, the stock has a significant upside potential with an analyst price target of $125, representing a potential increase of 51.5% from the current price of $82.39. However, a key risk is the negative net income reported in recent quarters, with a net income of $17.96 million in Q2 2026, which indicates ongoing challenges in profitability.